Oral Curcumin With Piperine as Adjuvant Therapy for the Treatment of COVID-19: A Randomized Clinical Trial

Oral Curcumin With Piperine as Adjuvant Therapy for the Treatment of COVID-19: A Randomized Clinical Trial

Background: Coronavirus disease-2019 (COVID-19) has a wide range of pathophysiological effects. Curcumin, an active constituent of Curcuma longa (turmeric), has several properties, including anti-inflammatory, antioxidant, antiviral, anti-thrombotic, and anti-proliferative effects, which make it a p...

Full description

Bibliographic Details
Main Authors: Kirti S Pawar, Rahul N Mastud, Satheesh K Pawar, Samragni S Pawar, Rahul R Bhoite, Ramesh R Bhoite, Meenal V Kulkarni, Aditi R Deshpande
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Pharmacology
Subjects:
curcumin
COVID-19
adjuvant therapy
traditional medicine
anti-inflammatory
post-covid thromboembolic episodes
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.669362/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.669362/full

Similar Items